← Eichor
Study identifier: NCT05672225 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Two-channel IV-PCA With Dexmedetomidine

Condition: Analgesia, Patient-Controlled · Dexmedetomidine  ·  Sponsor: Korea University Guro Hospital

PhaseNA
Planned participants110
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Seok Kyeong Oh, M.D., Ph.D  ·  82-2-2626-3237  ·  nanprayboy@korea.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Korea University Guro HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05672225